Home >
Medicine Info >
Cerebrolysin Injection
Loading interface...

Cerebrolysin Injection

Manufactured bySUN PHARMA LABORATORIES LTD
ContainsCerebrolysin
Description
Cerebrolysin Injection is used for the treatment of cerebral disorders, cranial injuries, Alzheimer's disease, and various form of dementia. This medicine is not recommended for use in patients suffering from epilepsy and in patient's suffering from severe renal impairment.
QUICK LINKS:
Side effectsConcernsUsage

Side effects

Major & minor side effects for Cerebrolysin Injection

  • Loss of appetite
  • Headache
  • Fever
  • Lower back pain
  • Shortness of breath
  • Chills
  • Irregular heartbeat
  • Diarrhea
  • Injection site reactions
  • Vomiting
  • Indigestion

Uses of Cerebrolysin Injection

What is it prescribed for?

  • Stroke
  • Traumatic Brain Injury
  • Vascular Dementia
  • Alzheimer's disease
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The amount of time required for this medicine to show its action is not clinically established.
  • How long do the effects of this medicine last?
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.

Allergy

This medicine is not recommended for use in patients with a known allergy to Cerebrolysin or any other inactive ingredients present along with it.

Epilepsy

This medicine is not recommended for use in patients suffering from epilepsy due to the increased risk of worsening of the patient's condition.

Severe renal impairment

This medicine is not recommended for use in patients suffering from severe renal impairment due to the increased risk of worsening of the patient's condition.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.
General warnings

Seizure Disorders

This medicine should be used with caution in patients suffering from seizure disorders due to the increased risk of worsening of the patient's condition. Close monitoring of the clinical condition, appropriate dose adjustments, or replacement with a suitable alternative may be necessary in some cases based on the patient's condition.

Kidney Function impairment

This medicine should be used with caution in patients suffering from kidney diseases due to the increased risk of severe adverse effects. Regular monitoring of kidney function tests is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the patient's clinical condition.

Intravenous Administration

When used intravenously, up to 10 ml should be slowly administered over 3 minutes and if the dose is 10-50 ml, it should be infused within 15-60 minutes.

Intramuscular Administration

When used intramuscularly, up to 5 ml should be administered slowly over 3 minutes.

Use in Pediatrics

This medicine should be used with extreme caution in patients less than 18 years of age. Your doctor may prescribe this medicine if the benefits significantly outweigh the risks. In such a case, you will be monitored closely for any adverse effects.

Missed Dose

Since this medicine is usually administered by a qualified healthcare professional in the clinical/hospital setting, the likelihood of a missed dose is very low.

Overdose

Since this medicine is administered in the hospital or clinical setting by a qualified healthcare professional, the likelihood of an overdose is very low. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Antidepressants

MAO inhibitors

Disease interactions

Disease

Information not available.
Food interactions
Information not available.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
This medicine is usually administered in the clinical/hospital setting under the supervision of a qualified healthcare professional. Follow all the instructions given by your doctor. Inform the doctor if you have a known allergy to this medicine. Report all your current medicines as well as your medical conditions to the doctor before receiving this medicine.
Miscelleneous

Usage does not depend on food timings

To be taken as instructed by doctor

Does not cause sleepiness

How it works
The exact mechanism of action of this medicine is not clinically established. However, it is believed to work by improving the function of the nerve cells and preventing cell death and inflammation in the brain.
Legal Status

Approved

Unknown

Unknown

Unknown

Classification

Category

Nootropics

Schedule

Schedule H

[Internet]. Cerebrolysin.com. 2018 [cited 24 September 2018]. Available from:

http://www.cerebrolysin.com/fileadmin/redakteur/Cerebrolysin/PDF/Cerebrolysin/Cerebrolysin_Dosage_recommendation.pdf

[Internet]. Nootropicspot.com. 2018 [cited 24 September 2018]. Available from:

https://nootropicspot.com/wp-content/uploads/2017/08/Cerebrolysin.pdf

[Internet]. Cerebrolysin.com. 2018 [cited 24 September 2018]. Available from:

http://www.cerebrolysin.com/en/cerebrolysin/about-cerebrolysin/
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 24 May 2019

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.